Drug Trial Radar · NCT00616772
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Last checked: Nov 20, 2026Latest source record: Jul 2, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
682
Actual
Start
Feb 2008
Primary completion
Sep 2012
Study completion Sep 2012
Sponsor
- Lead sponsor
- AbbVie (prior sponsor, Abbott)AbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Feb 15, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to test the effect and safety of once daily ABT-335 on the thickness of the lining of the carotid artery (a blood vessel to the brain) in patients with abnormal blood lipids who have optimal levels of low density lipoprotein cholesterol ("bad cholesterol") after taking atorvastatin.
Conditions
- Coronary Artery Disease
- Coronary Heart Disease
- Dyslipidemia
Interventions
ABT-335Drug
Capsule
PlaceboDrug
Capsule
AtorvastatinOther
Capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Change in Mean Posterior-wall Carotid Intima-media Thickness (cIMT)Time frame: Baseline, 6 months, 12 months, 18 months, and 24 months
Locations
124 sites in 1 country. Site status is shown where the registry gives one.
Site Reference ID/Investigator# 6747
Chandler, Arizona
Site Reference ID/Investigator# 7089
Gilbert, Arizona
Site Reference ID/Investigator# 7097
Mesa, Arizona
Site Reference ID/Investigator# 26394
Phoenix, Arizona
Site Reference ID/Investigator# 6848
Scottsdale, Arizona
Site Reference ID/Investigator# 7059
Tempe, Arizona
Site Reference ID/Investigator# 7094
Tempe, Arizona
Site Reference ID/Investigator# 7098
Tempe, Arizona
Site Reference ID/Investigator# 25082
Anaheim, California
Site Reference ID/Investigator# 21347
Corona, California
Site Reference ID/Investigator# 21483
Garden Grove, California
Site Reference ID/Investigator# 21351
Huntington Beach, California
Site Reference ID/Investigator# 21346
Laguna Hills, California
Site Reference ID/Investigator# 21341
Long Beach, California
Site Reference ID/Investigator# 21342
Norwalk, California
Site Reference ID/Investigator# 21321
Santa Ana, California
Site Reference ID/Investigator# 26242
Tustin, California
Site Reference ID/Investigator# 15283
Arvada, Colorado
Site Reference ID/Investigator# 7085
Aurora, Colorado
Site Reference ID/Investigator# 6749
Denver, Colorado
Site Reference ID/Investigator# 7077
Denver, Colorado
Site Reference ID/Investigator# 7092
Golden, Colorado
Site Reference ID/Investigator# 7722
Littleton, Colorado
Site Reference ID/Investigator# 7721
Littleton, Colorado
Site Reference ID/Investigator# 11925
Aventura, Florida
Site Reference ID/Investigator# 15861
Boynton Beach, Florida
Site Reference ID/Investigator# 14422
Deerfield Beach, Florida
Site Reference ID/Investigator# 19281
Delray Beach, Florida
Site Reference ID/Investigator# 20881
Hollywood, Florida
Site Reference ID/Investigator# 20882
Kissimmee, Florida
Site Reference ID/Investigator# 19321
Melbourne, Florida
Site Reference ID/Investigator# 21353
Melbourne, Florida
Site Reference ID/Investigator# 18503
Melbourne, Florida
Site Reference ID/Investigator# 18841
Vero Beach, Florida
Site Reference ID/Investigator# 19961
Vero Beach, Florida
Site Reference ID/Investigator# 7166
West Palm Beach, Florida
Site Reference ID/Investigator# 6744
West Palm Beach, Florida
Site Reference ID/Investigator# 19301
Atlanta, Georgia
Site Reference ID/Investigator# 7051
Atlanta, Georgia
Site Reference ID/Investigator# 7109
Atlanta, Georgia
Showing 40 of 124 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.